Health X Platform Limited (NSE:HEALTHX)
274.50
-0.60 (-0.22%)
Nov 11, 2026, 2:06 PM IST
Health X Platform Revenue
Health X Platform had revenue of 4.60B INR in the quarter ending June 30, 2026, with 41.96% growth. This brings the company's total for the last twelve months to 15.13B, up 26.48% year-over-year. In the fiscal year ending March 31, 2026, Health X Platform had annual revenue of 13.75B with 18.72% growth. That makes Health X Platform the 19,074th largest company in the world by revenue and 1,066th in India.
Revenue (ttm)
15.13B
Revenue Growth
+26.48%
P/S Ratio
0.58
Revenue / Employee
5.48M
Employees
2,760
Market Cap
8.73B
Revenue by Segment
- Healthcare Network 12.83B 97.3%
- Other 227.69M 1.7%
- Financial Services 133.36M 1.0%
Fiscal year ended Mar 31, 2026 See the full Health X Platform breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 13.75B | 2.17B | 18.72% |
| Mar 31, 2025 | 11.58B | -2.73B | -19.07% |
| Mar 31, 2024 | 14.31B | 3.71B | 34.95% |
| Mar 31, 2023 | 10.61B | 4.22B | 66.06% |
| Mar 31, 2022 | 6.39B | 879.80M | 15.98% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Divi's Laboratories | 121.91B |
| Lenskart Solutions | 103.83B |
| Laurus Labs | 78.23B |
| Remus Pharmaceuticals | 10.69B |
| Sigachi Industries | 4.91B |
| Amanta Healthcare | 3.04B |
| Max India | 2.84B |